丹参
生物合成
赤霉素
转录因子
生物化学
化学
转录组
生物
基因
植物
基因表达
医学
病理
中医药
替代医学
作者
Cuicui Han,Xingwen Dong,Xiaowen Xing,Yun Wang,Xiaobing Feng,Wenjuan Sang,Yifei Feng,Luyao Yu,Mengxuan Chen,Hongyuan Hao,Taohong Huang,Bailin Li,Wenhui Wu,Zheng Zhou,Ying He
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2024-12-13
卷期号:29 (24): 5892-5892
被引量:7
标识
DOI:10.3390/molecules29245892
摘要
Salvia miltiorrhiza, the valuable traditional Chinese medicinal plant, has been used in clinics for thousands of years. The water-soluble salvianolic acid compounds are bioactive substances used in treating many diseases. Gibberellins (GAs) are growth-promoting phytohormones that regulate plant growth and development. Previous studies have demonstrated that GAs can promote salvianolic acid accumulation in S. miltiorrhiza; however, the underlying mechanism requires further investigation. Here, we identified a GA-induced R2R3MYB transcription factor (TF), SmMYB71, from a transcriptome library of GA-treated S. miltiorrhiza. SmMYB71 was highly expressed in the root of S. miltiorrhiza and localized to the nucleus. SmMYB71-knockout hairy roots showed higher salvianolic acid accumulation compared to wild lines. Overexpressing SmMYB71 in S. miltiorrhiza hairy roots significantly decreased the content of salvianolic acid by downregulating key salvianolic acid biosynthesis enzymes such as SmRAS and SmCYP98A14. The GCC box in the promoter of SmMYB71 can bind with SmERF115, suggesting that SmMYB71 is regulated by SmERF115 in salvianolic acid biosynthesis. These findings demonstrate a novel regulatory role of SmMYB71 in GA-mediated phenolic acid biosynthesis. With the development of CRISPR/Cas9-based genome editing technology, the SmMYB71 regulation mechanism of salvianolic acid biosynthesis provides a potential target gene for metabolic engineering to increase the quality of S. miltiorrhiza.
科研通智能强力驱动
Strongly Powered by AbleSci AI